# A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

> **NCT00231634** · PHASE3 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 31 (actual)

## Conditions studied

- Obesity
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Adult-Onset

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00231634
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Program discontinued
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231634, "A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00231634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*